-
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS AND RISK OF PARKINSON’S DISEASE IN PATIENTS WITH OBESITY
Mar 18, 2026, 21:38 PM -
GEOGRAPHIC DISPARITIES IN TREATMENT ACCESS FOR TEXAS MEDICAID PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
Mar 18, 2026, 21:38 PM -
YEARS LOST: QUANTIFYING THE HUMAN COST OF DELAYED GENETIC DIAGNOSIS
Mar 18, 2026, 21:38 PM -
WHAT MATTERS MOST TO PATIENTS IN WARFARIN MODELS OF CARE: A QUALITATIVE STUDY
Mar 18, 2026, 21:38 PM -
BREAK EVEN ANALYSIS FOR CONTRACEPTION PRESCRIBING SERVICES IN COMMUNITY PHARMACIES
Mar 18, 2026, 21:38 PM -
INVESTIGATING THE CHARACTERISTICS ASSOCIATED WITH PRESCRIBED OPIOID USE IN U.S. ADULTS WITH LONG COVID
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS AND BUDGET IMPACT OF THE ETONOGESTREL SUBDERMAL IMPLANT INCORPORATING REAL-WORLD UTILIZATION DATA FROM A LARGE BRAZILIAN PRIVATE HEALTH INSURER
Mar 18, 2026, 21:38 PM -
DIRECT MEDICAL COSTS SAVED BY EARLY PAH DETECTION USING A MACHINE LEARNING ALGORITHM
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATIONS OF HYPERTENSION INTERVENTIONS IN PREGNANCY LACK STANDARDISATION: RESULTS OF A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
UTILIZATION OF TARLATAMAB AND ASSOCIATED HEALTHCARE RESOURCE USE, COSTS, AND ADVERSE EVENTS: A RETROSPECTIVE COHORT STUDY USING A LARGE U.S. HOSPITAL DATABASE
Mar 18, 2026, 21:38 PM -
EXCESS HEALTHCARE COSTS OF OVERT HEPATIC ENCEPHALOPATHY (OHE) RELATIVE TO NON-OHE CIRRHOSIS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
A SURVEY OF HEOR LEADERS IN PHARMA ABOUT THE STATE OF HEOR
Mar 18, 2026, 21:38 PM -
APPROVED AND EMERGING OPTIONS FOR ONCOLOGY TREATMENT-RELATED TOXICITIES: A TARGETED LITERATURE REVIEW OF THE LANDSCAPE AND REMAINING UNMET NEEDS
Mar 18, 2026, 21:38 PM -
ADVANCING CLINICAL DEVELOPMENT AND EVIDENCE GENERATION THROUGH CAUSAL AI: A TARGETED REVIEW OF APPLICATIONS AND IMPLICATIONS FOR REGULATORY-GRADE EVIDENCE
Mar 18, 2026, 21:38 PM -
IMPACT OF GLP-1 RECEPTOR AGONIST (GLP-1 RAS) PERSISTENCE VERSUS DISCONTINUATION ON CARDIOMETABOLIC MEASURES IN POLYCYSTIC OVARY SYNDROME (PCOS) OVER A TWO-YEAR FOLLOW-UP
Mar 18, 2026, 21:38 PM -
CHANGES IN PAIN AND STIFFNESS EXPERIENCED BY PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE MANEUVER PHASE 3 TRIAL: INSIGHTS FROM EXIT INTERVIEWS
Mar 18, 2026, 21:38 PM -
COMBINING PLASMA COLLECTION WITH DEMAND DIVERSION TO ACHIEVE IMMUNOGLOBULIN SELF-SUFFICIENCY IN CANADA
Mar 18, 2026, 21:38 PM -
DECODING THE PREDICTIVE ROLE OF COMPLETE RESPONSE/REMISSION RATE (CR) FOR OVERALL SURVIVAL (OS) IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Mar 18, 2026, 21:38 PM -
PREFERENCES FOR LONG-ACTING PREP ADMINISTRATION AMONG MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
PATIENT EXPERIENCES WITH HEALTH CARE TRANSITION IN YOUNG ADULTS WITH SICKLE CELL DISEASE
Mar 18, 2026, 21:38 PM
